Glucocorticoid-induced Osteoporosis

Overview

Journal Curr Rheumatol Rep

Publisher Current Science

Specialty Rheumatology

Date 2000 Dec 21

PMID 11123040

Citations 3

Authors

P Boulos

G Ioannidis

J D Adachi

Affiliations

Soon will be listed here.

Abstract

This article attempts to evaluate the results of several recently published clinical trials of drugs used in the treatment and prevention of glucocorticoid-induced osteoporosis. Despite our lack of understanding regarding the biological mechanisms that lead to glucocorticoid-induced bone loss, effective therapy has been developed. Bisphosphonates have demonstrated significant treatment benefits and should be considered the therapy of choice for both the treatment and prevention of glucocorticoid-induced osteoporosis.

Citing Articles

Glucocorticoids and osteocyte autophagy.

Yao W, Dai W, Jiang J, Lane N Bone. 2013; 54(2):279-84.

PMID: 23356984 PMC: 3784314. DOI: 10.1016/j.bone.2013.01.034.

Green tea polyphenols attenuate deterioration of bone microarchitecture in female rats with systemic chronic inflammation.

Shen C, Yeh J, Samathanam C, Cao J, Stoecker B, Dagda R Osteoporos Int. 2010; 22(1):327-37.

PMID: 20306019 DOI: 10.1007/s00198-010-1209-2.

Synergistic effects of green tea polyphenols and alphacalcidol on chronic inflammation-induced bone loss in female rats.

Shen C, Yeh J, Cao J, Tatum O, Dagda R, Wang J Osteoporos Int. 2010; 21(11):1841-52.

PMID: 20069278 PMC: 2919589. DOI: 10.1007/s00198-009-1122-8.

References

Nordborg E, Schaufelberger C, Andersson R, Bosaeus I, Bengtsson B . The ineffectiveness of cyclical oral clodronate on bone mineral density in glucocorticoid-treated patients with giant-cell arteritis. J Intern Med. 1998; 242(5):367-71. DOI: 10.1046/j.1365-2796.1997.00210.x. View

Lems W, Jacobs J, Bijlsma J, van Veen G, Houben H, Haanen H . Is addition of sodium fluoride to cyclical etidronate beneficial in the treatment of corticosteroid induced osteoporosis?. Ann Rheum Dis. 1997; 56(6):357-63. PMC: 1752400. DOI: 10.1136/ard.56.6.357. View

Sambrook P, Birmingham J, Kelly P, Kempler S, Nguyen T, Pocock N . Prevention of corticosteroid osteoporosis. A comparison of calcium, calcitriol, and calcitonin. N Engl J Med. 1993; 328(24):1747-52. DOI: 10.1056/NEJM199306173282404. View

Gonnelli S, Rottoli P, Cepollaro C, Pondrelli C, Cappiello V, Vagliasindi M . Prevention of corticosteroid-induced osteoporosis with alendronate in sarcoid patients. Calcif Tissue Int. 1997; 61(5):382-5. DOI: 10.1007/s002239900352. View

Baylink D . Glucocorticoid-induced osteoporosis. N Engl J Med. 1983; 309(5):306-8. DOI: 10.1056/NEJM198308043090509. View

Roux C, Oriente P, Laan R, Hughes R, Ittner J, Goemaere S . Randomized trial of effect of cyclical etidronate in the prevention of corticosteroid-induced bone loss. Ciblos Study Group. J Clin Endocrinol Metab. 1998; 83(4):1128-33. DOI: 10.1210/jcem.83.4.4742. View

Adinoff A, Hollister J . Steroid-induced fractures and bone loss in patients with asthma. N Engl J Med. 1983; 309(5):265-8. DOI: 10.1056/NEJM198308043090502. View

Lane N, Sanchez S, Modin G, Genant H, Pierini E, Arnaud C . Parathyroid hormone treatment can reverse corticosteroid-induced osteoporosis. Results of a randomized controlled clinical trial. J Clin Invest. 1998; 102(8):1627-33. PMC: 509014. DOI: 10.1172/JCI3914. View

Canalis E . Clinical review 83: Mechanisms of glucocorticoid action in bone: implications to glucocorticoid-induced osteoporosis. J Clin Endocrinol Metab. 1996; 81(10):3441-7. DOI: 10.1210/jcem.81.10.8855781. View

10.

Gough A, Lilley J, Eyre S, Holder R, Emery P . Generalised bone loss in patients with early rheumatoid arthritis. Lancet. 1994; 344(8914):23-7. DOI: 10.1016/s0140-6736(94)91049-9. View

11.

Chavassieux P, Pastoureau P, CHAPUY M, Delmas P, Meunier P . Glucocorticoid-induced inhibition of osteoblastic bone formation in ewes: a biochemical and histomorphometric study. Osteoporos Int. 1993; 3(2):97-102. DOI: 10.1007/BF01623380. View

12.

Boutsen Y, Jamart J, Esselinckx W, Stoffel M, Devogelaer J . Primary prevention of glucocorticoid-induced osteoporosis with intermittent intravenous pamidronate: a randomized trial. Calcif Tissue Int. 1997; 61(4):266-71. DOI: 10.1007/s002239900334. View

13.

Locascio V, Bonucci E, IMBIMBO B, Ballanti P, Adami S, Milani S . Bone loss in response to long-term glucocorticoid therapy. Bone Miner. 1990; 8(1):39-51. DOI: 10.1016/0169-6009(91)90139-q. View

14.

Sambrook P, Kelly P, Fontana D, Nguyen T, Keogh A, Macdonald P . Mechanisms of rapid bone loss following cardiac transplantation. Osteoporos Int. 1994; 4(5):273-6. DOI: 10.1007/BF01623351. View

15.

Suzuki Y, Ichikawa Y, Saito E, Homma M . Importance of increased urinary calcium excretion in the development of secondary hyperparathyroidism of patients under glucocorticoid therapy. Metabolism. 1983; 32(2):151-6. DOI: 10.1016/0026-0495(83)90221-4. View

16.

Wolfhagen F, van Buuren H, den Ouden J, Hop W, van Leeuwen J, Schalm S . Cyclical etidronate in the prevention of bone loss in corticosteroid-treated primary biliary cirrhosis. A prospective, controlled pilot study. J Hepatol. 1997; 26(2):325-30. DOI: 10.1016/s0168-8278(97)80048-7. View

17.

Adachi J, Bensen W, Brown J, Hanley D, Hodsman A, Josse R . Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis. N Engl J Med. 1997; 337(6):382-7. DOI: 10.1056/NEJM199708073370603. View

18.

Liberman U, Weiss S, Broll J, Minne H, Quan H, Bell N . Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group. N Engl J Med. 1995; 333(22):1437-43. DOI: 10.1056/NEJM199511303332201. View

19.

Aman S, Hakala M, Silvennoinen J, Manelius J, Risteli L, Risteli J . Low incidence of osteoporosis in a two year follow-up of early community based patients with rheumatoid arthritis. Scand J Rheumatol. 1998; 27(3):188-93. DOI: 10.1080/030097498440796. View

20.

Lems W, Jacobs W, Bijlsma J, Croone A, Haanen H, Houben H . Effect of sodium fluoride on the prevention of corticosteroid-induced osteoporosis. Osteoporos Int. 1997; 7(6):575-82. DOI: 10.1007/BF02652565. View